Reinhardt?

Richard Reinhardt (1909–1987) was a German bacteriologist and epidemiologist who, after surviving the Second World War as a laboratory technician in military hospitals, became the founding director and principal architect of the Institute for the History of Bacteriology. His work established the historical study of infection control as a distinct discipline and produced the first systematic documentation of how asepsis maximalism came to govern medical practice in the post-war decades.

Reinhardt was born in Berlin to a family of pharmacists and studied bacteriology at the University of Berlin in the early 1930s, just as the azo drugs were entering clinical use. His early publications examined sulfonamide efficacy in acute wound infections, but his career was interrupted by wartime conscription. From 1943 to 1945, he worked in a surgical bacteriology laboratory supporting Wehrmacht field hospitals, where he observed directly the limitations of the azo drugs against secondary infections in severe trauma. A typescript from this period, preserved in the institute's archives, notes that even optimal sulfonamide dosing could not prevent gangrene in contaminated crush injuries—a reality that marked Reinhardt's subsequent thinking.

After the war, Reinhardt joined the newly formed Geneva Sanitary Bureau, where he spent much of the late 1940s collecting infection statistics from European hospitals for the preparatory discussions that led to the Bacillary Congress of Geneva in 1952. He did not attend the congress itself, but his statistical compilation—a 400-page appendix to the official proceedings detailing infection rates, surgical outcomes, and ward protocols across seventeen nations from 1935 to 1950—became the evidentiary foundation for the congress's recommendations on asepsis maximalism. The data showed plainly that hospitals with the strictest contamination control had measurably lower infection mortality, a finding that hospitals with the most permissive protocols could not match.

In 1956, Reinhardt founded the Institute for the History of Bacteriology in Berlin with funding from the West German health ministry and support from the director of the Pasteur Institute in Paris. His charge was unconventional for the time: not to advance bacteriology itself, but to create a permanent archive documenting how bacterial infection had shaped modern medicine and public health. The institute collected original laboratory notebooks, surgical protocols, ward records, and correspondence from hundreds of physicians and researchers. Reinhardt himself conducted extensive oral interviews with surgeons and bacteriologists who had lived through the early years of the azo drugs and the turn toward prevention-based medicine.

Reinhardt's major works were three monographs published between 1962 and 1975: The Asepsis Transition: Infection Control Doctrine Before and After 1952, Sulfonamide Efficacy in Clinical Practice, 1936-1955, and The Architecture of Prevention: Hospital Design and Infection Outcomes. In these works, Reinhardt argued that asepsis maximalism was not simply a rational response to the limits of chemical treatment but an outcome of specific institutional decisions and architectural constraints. He documented, for instance, how hospital design in the 1950s and 1960s incorporated increasingly elaborate airlocks, sealed operating theatres, and disposable material protocols—infrastructure that then shaped medical practice for decades afterward, sometimes in ways that had outlasted their original rationale.

A scholarly dispute has persisted over Reinhardt's interpretation of the causal relationship between the failure of antibacterial chemotherapy and the rise of prevention-based medicine. Reinhardt himself emphasized that the congress merely formalized practices already underway in leading hospitals; critics, particularly those affiliated with the history departments of the University of Geneva and University of Stockholm, contend that Reinhardt understated the role of the congress in actively directing hospital investment and training toward asepsis over treatment, creating a self-reinforcing institutional bias. The dispute remains largely semantic—the evidence Reinhardt gathered supports both readings—but it reflects different interpretations of how much medical doctrine is discovered versus invented.

Reinhardt retired from the institute in 1979 and died in Berlin in 1987. He left no direct successor, and the institute continued under a succession of directors without his unifying intellectual project. His archival work, however, became the standard reference base for historians of twentieth-century medicine, infection control, and public health. The institute's collections remain the primary documentary source for understanding how hospitals, governments, and physicians adapted to a world in which infection could be prevented but not reliably cured.